These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36283468)

  • 1. The interplay between MMP-12 and t-PA in the brain after ischemic stroke.
    Challa SR; Nalamolu KR; Fornal CA; Mohandass A; Mussman JP; Schaibley C; Kashyap A; Sama V; Wang BC; Klopfenstein JD; Pinson DM; Kunamneni A; Veeravalli KK
    Neurochem Int; 2022 Dec; 161():105436. PubMed ID: 36283468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinase-12 Induces Blood-Brain Barrier Damage After Focal Cerebral Ischemia.
    Chelluboina B; Klopfenstein JD; Pinson DM; Wang DZ; Vemuganti R; Veeravalli KK
    Stroke; 2015 Dec; 46(12):3523-31. PubMed ID: 26534974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
    Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
    Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP-12 knockdown prevents secondary brain damage after ischemic stroke in mice.
    Arruri V; Chokkalla AK; Jeong S; Chelluboina B; Mehta SL; Veeravalli KK; Vemuganti R
    Neurochem Int; 2022 Dec; 161():105432. PubMed ID: 36252818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
    Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective mechanism of Erigeron breviscapus injection on blood-brain barrier injury induced by cerebral ischemia in rats.
    Liu G; Liang Y; Xu M; Sun M; Sun W; Zhou Y; Huang X; Song W; Liang Y; Wang Z
    Sci Rep; 2021 Sep; 11(1):18451. PubMed ID: 34531475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
    Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LOX-1 and MMP-9 Inhibition Attenuates the Detrimental Effects of Delayed rt-PA Therapy and Improves Outcomes After Acute Ischemic Stroke.
    Arkelius K; Wendt TS; Andersson H; Arnou A; Gottschalk M; Gonzales RJ; Ansar S
    Circ Res; 2024 Apr; 134(8):954-969. PubMed ID: 38501247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia.
    Liu W; Hendren J; Qin XJ; Shen J; Liu KJ
    J Neurochem; 2009 Feb; 108(3):811-20. PubMed ID: 19187098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angong Niuhuang Wan reduces hemorrhagic transformation and mortality in ischemic stroke rats with delayed thrombolysis: involvement of peroxynitrite-mediated MMP-9 activation.
    Chen H; Luo Y; Tsoi B; Gu B; Qi S; Shen J
    Chin Med; 2022 Apr; 17(1):51. PubMed ID: 35477576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.
    Gidday JM; Gasche YG; Copin JC; Shah AR; Perez RS; Shapiro SD; Chan PH; Park TS
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H558-68. PubMed ID: 15764676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice.
    Zechariah A; ElAli A; Hermann DM
    Stroke; 2010 May; 41(5):1008-12. PubMed ID: 20360548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that enolase-phosphatase 1 exacerbates early cerebral ischemia injury and blood-brain barrier breakdown by enhancing extracellular matrix destruction and inhibiting the interaction between ADI1 and MT1-MMP.
    Yang D; Su L; Li X; Xie C; Zhang Y
    Exp Neurol; 2023 Jul; 365():114410. PubMed ID: 37075968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage.
    Liu J; Jin X; Liu KJ; Liu W
    J Neurosci; 2012 Feb; 32(9):3044-57. PubMed ID: 22378877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
    Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levofloxacin alleviates blood-brain barrier disruption following cerebral ischemia and reperfusion via directly inhibiting A-FABP.
    Yang S; Xu D; Zhang D; Huang X; Li S; Wang Y; Lu J; Wang D; Guo ZN; Yang Y; Ye D; Wang Y; Xu A; Hoo RLC; Chang J
    Eur J Pharmacol; 2024 Jan; 963():176275. PubMed ID: 38113968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential.
    Machado LS; Sazonova IY; Kozak A; Wiley DC; El-Remessy AB; Ergul A; Hess DC; Waller JL; Fagan SC
    Stroke; 2009 Sep; 40(9):3028-33. PubMed ID: 19628804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycyrrhizin Prevents Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke with Delayed Thrombolysis Through Targeting Peroxynitrite-Mediated HMGB1 Signaling.
    Chen H; Guan B; Wang B; Pu H; Bai X; Chen X; Liu J; Li C; Qiu J; Yang D; Liu K; Wang Q; Qi S; Shen J
    Transl Stroke Res; 2020 Oct; 11(5):967-982. PubMed ID: 31872339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
    Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
    J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.